Synapse - Works

Results (115603)

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient reported outcomes from GRIFFIN

Meeting Abstract

Silbermann, R.; Laubach, J.; Kaufman, J. L.; Sborov, D. W.; Reeves, B.; Rodriguez, C.; Chari, A.; Costa, L. J.; Anderson, L. D. Jr; Nathwani, N.; more...
Blood (2022)

Fulltext@MSK | Save

Donor-derived amphiregulin drives CD4(+) T cell expansion and promotes tissue pathology after experimental allogeneic BMT

Meeting Abstract

Ito, T.; Takashima, S.; Calafiore, M.; Fu, Y. Y.; Egorova, A.; Kuttiyara, J.; Chang, W.; Vinci, P.; Arnhold, V.; Zaiss, D.; more...
Blood (2022)

Fulltext@MSK | Save

Subcutaneous epcoritamab + R-DHAX/C in patients with relapsed or refractory diffuse large B-cell lymphoma eligible for autologous stem cell transplant: Updated phase 1/2 results

Meeting Abstract

Abrisqueta, P.; Cordoba, R.; Falchi, L.; de Vos, S.; Nijland, M.; Offner, F.; Wu, J.; Bykhovski, I.; Wang, L.; Rana, A.; more...
Blood (2022)

Fulltext@MSK | Save

RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients

Meeting Abstract

Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
Blood (2022)

Fulltext@MSK | Save

Genomic determinants of resistance in newly diagnosed multiple myeloma treated with targeted-immunotherapy

Meeting Abstract

Maura, F.; Boyle, E.; Coffey, D.; Maclachlan, K. H.; Diamond, B.; Blaney, P.; Gagler, D.; Ziccheddu, B.; Ghamlouch, H.; Wang, Y.; more...
Blood (2022)

Fulltext@MSK | Save

Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: Subgroup analysis of MAIA Trial

Meeting Abstract

Perrot, A.; Facon, T.; Plesner, T.; Usmani, S.; Kumar, S. K.; Bahlis, N. J.; Hulin, C.; Orlowski, R. Z.; Nahi, H.; Mollee, P.; more...
Blood (2022)

Fulltext@MSK | Save

A simplified patient care strategy to decrease early deaths in acute promyelocytic leukemia (APL): Results of the ECOG-ACRIN EA9131 trial

Meeting Abstract

Jillella, A. P.; Lee, S. J.; Altman, J. K.; Luger, S. M.; Tallman, M. S.; Foran, J. M.; Law, L. Y.; Bryan, L. J.; Abou Zahr, A.; Begna, K.; more...
Blood (2022)

Fulltext@MSK | Save

Relapse is uncommon in patients with large B-cell lymphoma who are in complete remission at the end of fixed-course glofitamab treatment

Meeting Abstract

Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Bachy, E.; Corradini, P.; Iacoboni, G.; Khan, C.; Patel, K.; Hertzberg, M.; Falchi, L.; more...
Blood (2022)

Fulltext@MSK | Save

Polatuzumab vedotin combined with R-ICE (PolaR-ICE) as second-line therapy in relapsed/refractory diffuse large B-cell lymphoma

Meeting Abstract

Herrera, A. F.; Chen, L.; Crombie, J. L.; Cohen, J. B.; Advani, R. H.; LaCasce, A. S.; Popplewell, L. L.; Puverel, S.; Peters, L.; Daniels, S.; more...
Blood (2022)

Fulltext@MSK | Save

Allogeneic but not autologous stem cell transplantation improves outcome in HTLV-1-associated North American adult T-cell leukemia/lymphoma

Meeting Abstract

Bazarbachi, A. H.; Reef, D. K.; Narvel, H.; Patel, R.; Al Hamed, R.; Thakkar, A.; Rahman, S.; Shah, U. A.; Herrera, D. A.; Quinn, R.; more...
Blood (2022)

Fulltext@MSK | Save